North Texas Angel Network

The North Texas Angel Network, established in 2008 and based in Dallas, Texas, focuses on investing in early-stage companies with promising products and potential for growth. Comprising over sixty successful entrepreneurs and business professionals, the network not only provides essential investment funds but also offers valuable experience and expertise to help these companies succeed. The group's commitment to innovation drives its investment strategy, making it a significant player in the support and development of emerging businesses in the region.

Mike Bartlett

Co-Founder and Chairman

8 past transactions

One Health Group

Seed Round in 2024
One Health Group develops a health assessment platform that uses intelligent sensors and artificial intelligence for health information. One Health Group supports an innovative network and culture. For the benefit of health and wellness in the future, they are dedicated to developing and implementing new technologies.

PodUp

Pre Seed Round in 2024
PodUp is a platform that simplifies podcast creation, production, and monetization. It equips users with integrated tools to enhance productivity and elevate podcasting experiences, enabling influencers and businesses to expand their audience and boost earnings.

Gardenuity

Seed Round in 2023
Gardenuity is an e-commerce startup focused on making gardening accessible to a wide audience. The company offers a variety of home gardening products, including natural and non-genetically modified garden components. Gardenuity provides delivery of customized gardening kits that are tailored to fit individual landscapes, featuring live plants and seeds suitable for both indoor and outdoor crops. This approach aims to assist gardening enthusiasts and landscape specialists by offering an array of unique decor and garden accessories, ultimately transforming the way consumers create and maintain their gardens.

Tella Firma

Angel Round in 2015
Founded in 2015, Tella Firma specializes in solid earth foundation solutions for luxury custom homes, multifamily units, commercial offices, and warehouses. The company's innovative construction technology elevates slab-on-grade foundations using piers, creating a protective void between the ground and the foundation to safeguard against damage from active clay soils or seismic activity.

Retrotope

Series B in 2015
Retrotope Inc. is a biotechnology company based in Los Altos, California, focused on developing innovative therapeutics for degenerative diseases. Founded in 2006, Retrotope specializes in preserving and restoring mitochondrial health, addressing conditions associated with oxidative stress. The company’s primary therapeutic candidates target a range of neurological disorders, including Parkinson's disease, Alzheimer's disease, and specific mitochondrial myopathies. Notably, Retrotope is developing RT001, a drug aimed at treating infantile neuroaxonal dystrophy. Through its unique drug platform, Retrotope employs isotope effects to mitigate cellular damage caused by lipid peroxidation, positioning itself as a leader in the treatment of intractable and degenerative disorders. The company engages in multiple discovery and development programs, emphasizing its commitment to advancing healthcare solutions for challenging neurological conditions.

AdBm Technologies

Series A in 2014
AdBm Technologies is an acoustical engineering company that develops underwater noise abatement solutions for marine environments. It focuses on environmental engineering, marine technology, and mechanical engineering, and employs arrays of Helmholtz resonators tuned to specific frequencies to capture and reduce noise from industrial operations at sea, with the goal of protecting marine wildlife. Founded in 2012, the company is based in Austin, Texas.

Vital Art and Science

Series A in 2013
Vital Art and Science, founded in 2006 and based in Dallas, Texas, specializes in developing handheld applications for diagnosing and monitoring age-related macular degeneration and diabetic retinopathy. The company's flagship product, myVisionTrack, empowers patients with these conditions to test and monitor their retinal function conveniently from home. This innovative solution aims to enhance the efficiency of vision monitoring for individuals with retinal diseases.

Carnegie Speech

Series A in 2007
Carnegie Speech Company, Inc. is a technology firm specializing in software that assesses and teaches spoken language skills, particularly in English. Founded in 2001 and based in Pittsburgh, Pennsylvania, the company offers a range of products designed to enhance language proficiency for both individuals and organizations. Its flagship product, Carnegie Speech Assessment, provides precise evaluations of pronunciation, grammar, and fluency, enabling users to make informed decisions in hiring and training contexts. The NativeAccent software delivers targeted pronunciation training, utilizing advanced techniques in speech recognition and artificial intelligence to identify and correct specific errors. Additionally, Carnegie Speech offers Climb Level 4, tailored for international pilots and air traffic controllers preparing for aviation English certification. The company's solutions are accessible through various platforms, including desktop and web, and are distributed via resellers and its online store, serving sectors such as business, education, aviation, and healthcare globally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.